LONDON--(BUSINESS WIRE)--Technavio market research analysts forecast the global urinalysis market to grow at a CAGR of more than 4% during the forecast period, according to their latest report.
The market study covers the present scenario and growth prospects of the global urinalysis market for 2017-2021. The global urinalysis market is segregated into instruments and consumables. The technologically advanced POCT instruments (fully automated analyzers, dipsticks, and reagents) for application areas such as diabetes and pregnancy are witnessing increased demand.
Srinivas Sashidar, a lead research analyst for in-vitro diagnostics at Technavio says, “The development of new techniques and testing platforms for diagnosis of infectious diseases has changed the protocol for detection of causative organisms of infectious diseases. Advances in technology have improved the testing methods for UTI, as they more accurate and sensitive, and provide faster outcomes and a broader range of pathogen detection compared with most traditional methods.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio analysts highlight the following three market drivers that are contributing to the growth of the global urinalysis market:
- Rising prevalence of UTI in hospitals
- Technological advances
- Favorable reimbursement of urinary catheters
Rising prevalence of UTI in hospitals
Urinary tract infections (UTIs) leading to incontinence have increased and are very common in the elderly population. Most cases are due to urinary disorders or abnormalities that reduce the control over the bladder. This includes disorders such as Parkinson’s disease, incontinence due to old age, multiple sclerosis, and dementia. Therefore, most of the demand for urinalysis analyzers or consumables comes from the elderly population. According to the CDC, around 75% of UTIs acquired in the hospital are associated with a urinary catheter, which is a tube inserted into the bladder through the urethra to drain urine. Hence, the increase in the number of urinary infections in patients drives the urinalysis market across the globe.
Technological advances
The advances in the field of clinical and laboratory diagnostics have enabled faster detection and treatment of many diseases by the process of urinalysis. Continuous innovations in technology are increasing the performance and speed of clinical/laboratory diagnostics and play an integral part in decision-making while performing a disease test. The increase in infectious diseases and early detection of non-communicable diseases such as UTI, diabetes, kidney stones, or liver disorders are some of the strongest areas within the urinalysis field.
“The market may witness more product launches with advanced features in the next few years. Vendors are also focusing on introducing innovative testing kits for the rapid detection of various microbes,” says Srinivas.
Favorable reimbursement of urinary catheters
Favorable reimbursements have increased the demand for urinalysis tests in the market. As part of Obamacare, especially for catheter-assisted urinary tract infection (CAUTI), Medicare considers an intermittent catheter as a prosthetic benefit to an individual who has permanent urinary incontinence.
Urinalysis is one of the most useful indicators of health and disease, thus helping in the detection of renal or metabolic disorders. It aids in diagnosing and following the course of treatment in kidney and urinary system diseases and in detecting disorders in other parts of the body such as metabolic or endocrinological abnormalities in which the kidneys function normally. Urinalysis tests are covered by Medicare Payments Urinalysis procedures (81002 or 81003) when billed in conjunction with any E&M service.
Browse Related Reports:
- IVD Market in China 2017-2021
- Global Women's Health Diagnostics Market 2017-2021
- Global POC Lipid Testing Market 2017-2021
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like oncology, vaccines, and cardiovascular devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
